Baycol (cerivastatin sodium tablets)

Audience: Primary Care Physicians and other health professionals

Bayer Corporation has notified healthcare professionals of changes in the prescribing information for Baycol, providing more specific guidance on initiating therapy and dose adjustment in order to reduce the risk of myopathy and rhabdomyolysis.

[June 26, 2001 - Letter - Bayer Corp.]